Liver-Directed Therapy for Neuroendocrine Metastases: From Interventional Radiology to Nuclear Medicine Procedures

SIMPLE SUMMARY: Approximately 80% of metastatic patients with gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) have secondary hepatic lesions, and in approximately 50% of cases, the liver is the only metastatic site. In patients with hepatic metastases from NENs for whom surgical treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Cazzato, Roberto Luigi, Hubelé, Fabrice, De Marini, Pierre, Ouvrard, Eric, Salvadori, Julien, Addeo, Pietro, Garnon, Julien, Kurtz, Jean-Emmanuel, Greget, Michel, Mertz, Luc, Goichot, Bernard, Gangi, Afshin, Imperiale, Alessio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699378/
https://www.ncbi.nlm.nih.gov/pubmed/34944988
http://dx.doi.org/10.3390/cancers13246368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699378/
https://www.ncbi.nlm.nih.gov/pubmed/34944988
http://dx.doi.org/10.3390/cancers13246368

Ejemplares similares